Shailja Mehta, MD
Undefined Physician Type (Specify) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mehta’s office at (650) 934-7000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A173315 · Current
Licensed to practise in California · since 2021 · expires 2027-06-30 · Rutgers New Jersey Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$151,120
Medicare paid this office $151,120 for 270 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 34 | $33,773 | None |
| New patient visit (60+ min) | 119 | $22,905 | $192 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 33 | $22,263 | $398 |
| Return visit (30+ min) | 76 | $10,751 | $112 |
| Insertion of lower leg neurostimulator electrode | 18 | $10,202 | $124 |
See all 11 services
| Botox | 34 | $33,773 | None |
| New patient visit (60+ min) | 119 | $22,905 | $192 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 33 | $22,263 | $398 |
| Return visit (30+ min) | 76 | $10,751 | $112 |
| Insertion of lower leg neurostimulator electrode | 18 | $10,202 | $124 |
| Long return visit (40+ min) | 51 | $8,769 | $162 |
| New patient visit (45+ min) | 24 | $3,348 | $140 |
| Simple bladder irrigation and/or instillation | 37 | $3,128 | $43 |
| Insertion of temporary bladder tube | 39 | $1,812 | $43 |
| Ultrasound measurement of bladder capacity after voiding | 136 | $1,761 | $12 |
| Short return visit (20+ min) | 18 | $1,439 | $76 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
270 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 10% · Women 100% · Also on Medicaid 12% · Health risk score 0.88. At or below the middle of the specialty; the typical undefined physician type clinician is at 1.67.
Conditions among them: High blood pressure 56% · Depression 25% · Diabetes 19% · Coronary heart disease 16% · Cancer 15% · Chronic kidney disease 14% · COPD 9% · Atrial fibrillation 8% · Heart failure 7% · Dementia 5% · Stroke 4%.
The office billed $580,744, Medicare allowed $196,329 and paid $151,120; for 8,071 services of 41 kinds; $37,653 of it was for drugs given in the office and $113,466 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 270 | 8,071 | 75 | 0.88 | $580,744 | $151,120 |
| 2023 | 224 | 2,831 | 76 | 0.85 | $315,418 | $78,271 |
| 2022 | 336 | 3,027 | 76 | 0.85 | $582,159 | $145,390 |
| 2021 | 37 | 55 | 76 | 0.95 | $26,996 | $7,591 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| New patient visit (60+ min) | 63 | $12,150 | $193 |
| Botox | 16 | $10,551 | None |
| Insertion of lower leg neurostimulator electrode | 36 | $9,161 | $116 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $7,592 | $400 |
| Return visit (30+ min) | 50 | $6,499 | $107 |
| Long return visit (40+ min) | 38 | $5,657 | $135 |
| New patient visit (45+ min) | 27 | $3,580 | $133 |
| Short return visit (20+ min) | 37 | $2,814 | $70 |
| Insertion of temporary bladder tube | 48 | $2,088 | $43 |
| Simple bladder irrigation and/or instillation | 19 | $1,003 | $44 |
| Ultrasound measurement of bladder capacity after voiding | 75 | $907 | $12 |
2022: 14 services
| Insertion of lower leg neurostimulator electrode | 79 | $28,651 | $123 |
| New patient visit (45+ min) | 129 | $18,080 | $140 |
| Return visit (30+ min) | 93 | $13,689 | $116 |
| New patient visit (60+ min) | 45 | $8,799 | $196 |
| Botox | 15 | $8,793 | None |
| Creation of sling around urethra in female to control leakage | 18 | $8,723 | $459 |
| Insertion of temporary bladder tube | 160 | $6,833 | $42 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 15 | $6,586 | $387 |
| Long return visit (40+ min) | 29 | $5,272 | $160 |
| Short return visit (20+ min) | 37 | $3,606 | $82 |
| Repair of herniated rectum into vaginal wall | 11 | $2,731 | $248 |
| Simple bladder irrigation and/or instillation | 17 | $1,347 | $54 |
| Short return visit | 11 | $582 | $53 |
| Ultrasound measurement of bladder capacity after voiding | 26 | $298 | $11 |
2021: 1 service
| Insertion of lower leg neurostimulator electrode | 16 | $2,469 | $137 |
Drugs they prescribed that Part D paid
$171,136
Pharmacies billed $171,136 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (25 of 593) in 2024. Above the middle of the specialty; the typical undefined physician type clinician is at 0%.
367 generic and 226 brand-name prescriptions · $171,136 in drug cost · 117 antibiotic prescriptions to 72 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 118 | $97,990 | $830 |
| Myrbetriq | 72 | $52,941 | $735 |
| Estradiol | 176 | $10,029 | $57 |
| Premarin | 15 | $6,619 | $441 |
| Nitrofurantoin Mono-Macro | 37 | $208 | $6 |
See all 10 drugs
| Gemtesa | 118 | $97,990 | $830 |
| Myrbetriq | 72 | $52,941 | $735 |
| Estradiol | 176 | $10,029 | $57 |
| Premarin | 15 | $6,619 | $441 |
| Nitrofurantoin Mono-Macro | 37 | $208 | $6 |
| Ibuprofen | 22 | $194 | $9 |
| Sulfamethoxazole-Trimethoprim | 45 | $132 | $3 |
| Oxycodone | 22 | $65 | $3 |
| Cephalexin | 16 | $64 | $4 |
| Ciprofloxacin | 16 | $44 | $3 |
Year by year
| 2024 | 593 | 240 | 4% (25) | 38% | $171,136 |
| 2023 | 410 | 146 | None | 53% | $163,080 |
| 2022 | 419 | 174 | 3% (13) | 43% | $87,248 |
| 2021 | 162 | 77 | None | 44% | $42,929 |
| 2020 | 254 | 130 | None | 41% | $44,630 |
| 2019 | 170 | 97 | None | None | $16,276 |
| 2018 | 16 | None | None | None | $186 |
| 2017 | 11 | None | None | None | $272 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Gemtesa | 98 | $88,470 | $903 |
| Myrbetriq | 61 | $46,457 | $762 |
| Premarin | 32 | $14,622 | $457 |
| Estradiol | 80 | $6,713 | $84 |
| Nitrofurantoin Mono-Macro | 46 | $1,364 | $30 |
| Cephalexin | 18 | $136 | $8 |
2022: 9 drugs
| Gemtesa | 42 | $28,218 | $672 |
| Premarin | 58 | $25,040 | $432 |
| Myrbetriq | 32 | $14,399 | $450 |
| Estradiol | 97 | $9,542 | $98 |
| Estring | 13 | $7,001 | $539 |
| Nitrofurantoin Mono-Macro | 55 | $947 | $17 |
| Ibuprofen | 17 | $166 | $10 |
| Cephalexin | 18 | $129 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $62 | $4 |
2021: 5 drugs
| Myrbetriq | 34 | $24,015 | $706 |
| Premarin | 23 | $9,713 | $422 |
| Estradiol | 19 | $2,086 | $110 |
| Methenamine Hippurate | 16 | $1,659 | $104 |
| Nitrofurantoin Mono-Macro | 16 | $539 | $34 |
2020: 7 drugs
| Myrbetriq | 49 | $25,154 | $513 |
| Premarin | 21 | $8,389 | $399 |
| Estradiol | 13 | $1,951 | $150 |
| Nitrofurantoin Mono-Macro | 43 | $1,834 | $43 |
| Solifenacin | 18 | $1,790 | $99 |
| Oxybutynin Chloride Er | 18 | $872 | $48 |
| Sulfamethoxazole-Trimethoprim | 14 | $33 | $2 |
2019: 4 drugs
| Myrbetriq | 15 | $6,072 | $405 |
| Nitrofurantoin Mono-Macro | 39 | $1,003 | $26 |
| Solifenacin | 14 | $795 | $57 |
| Sulfamethoxazole-Trimethoprim | 15 | $62 | $4 |
Money from drug and device companies
$1,570 in 2025
| 2025 | 2 | 7 | $1,425 | $1,570 |
| 2024 | 4 | 5 | None | $386 |
| 2023 | 1 | 1 | None | $29 |
| 2022 | 2 | 3 | None | $310 |
| 2021 | 2 | 2 | None | $93 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $1,539 | 6 payments
|
| Bluewind Medical | Revi | $31 | 1 payment
|
See all 7 published payments
| Abbvie | Paid to speak or teach · 2025-08-14 | Botox | $713 |
| Abbvie | Paid to speak or teach · 2025-08-08 | Botox | $713 |
| Abbvie | Meals · 2025-07-24 | Botox | $34 |
| Bluewind Medical | Meals · 2025-05-16 | Revi | $31 |
| Abbvie | Meals · 2025-05-15 | Botox | $25 |
| Abbvie | Meals · 2025-04-03 | Botox | $29 |
| Abbvie | Meals · 2025-01-18 | Botox | $26 |
See earlier years (2024, 2023, 2022, 2021)
2024: $386
| Boston Scientific | None | $168 | 1 payment
|
| Axonics | Axonics | $128 | 1 payment
|
| Abbvie | Botox | $64 | 2 payments
|
| FEMSelect | Enplace | $25 | 1 payment
|
2023: $29
| Caldera Medical | Desara | $29 | 1 payment
|
2022: $310
| Medtronic | Interstim | $174 | 1 payment
|
| Boston Scientific | Upsylon | $136 | 2 payments
|
2021: $93
| Coloplast | Altis | $64 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $29 | 1 payment
|
Professional record
- NPI
- 1578982880
- Licence
- CA A173315California A173315: Current · expires 2027-06-30
- Trained
- Rutgers New Jersey Medical School, 2014
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-04-15
- NPI last updated
- 2022-03-02
- NPI record certified
- 2022-03-02
This is when the NPI record was last certified, not a medical board exam.